vs

Side-by-side financial comparison of CMB.TECH NV (CMBT) and STEPAN CO (SCL). Click either name above to swap in a different company.

STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $592.8M, roughly 1.0× CMB.TECH NV). CMB.TECH NV runs the higher net margin — 32.3% vs 3.3%, a 29.0% gap on every dollar of revenue. On growth, STEPAN CO posted the faster year-over-year revenue change (1.9% vs -34.6%).

CMB.TECH, before October 2024 known as Euronav, is a crude oil tanker transport company, which consists of VLCCs, Suezmaxes and FSOs.

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

CMBT vs SCL — Head-to-Head

Bigger by revenue
SCL
SCL
1.0× larger
SCL
$604.5M
$592.8M
CMBT
Growing faster (revenue YoY)
SCL
SCL
+36.5% gap
SCL
1.9%
-34.6%
CMBT
Higher net margin
CMBT
CMBT
29.0% more per $
CMBT
32.3%
3.3%
SCL

Income Statement — Q4 FY2024 vs Q1 FY2026

Metric
CMBT
CMBT
SCL
SCL
Revenue
$592.8M
$604.5M
Net Profit
$191.2M
$19.7M
Gross Margin
10.7%
Operating Margin
46.4%
4.7%
Net Margin
32.3%
3.3%
Revenue YoY
-34.6%
1.9%
Net Profit YoY
-63.3%
EPS (diluted)
$1.01
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBT
CMBT
SCL
SCL
Q1 26
$604.5M
Q4 25
$553.9M
Q3 25
$590.3M
Q2 25
$594.7M
Q1 25
$593.3M
Q4 24
$592.8M
$525.6M
Q3 24
$546.8M
Q2 24
$556.4M
Net Profit
CMBT
CMBT
SCL
SCL
Q1 26
$19.7M
Q4 25
$5.0M
Q3 25
$10.8M
Q2 25
$11.3M
Q1 25
$19.7M
Q4 24
$191.2M
$3.4M
Q3 24
$23.6M
Q2 24
$9.5M
Gross Margin
CMBT
CMBT
SCL
SCL
Q1 26
10.7%
Q4 25
9.3%
Q3 25
12.0%
Q2 25
12.1%
Q1 25
12.7%
Q4 24
10.8%
Q3 24
13.8%
Q2 24
12.5%
Operating Margin
CMBT
CMBT
SCL
SCL
Q1 26
4.7%
Q4 25
1.9%
Q3 25
3.7%
Q2 25
3.0%
Q1 25
4.8%
Q4 24
46.4%
1.5%
Q3 24
4.4%
Q2 24
3.4%
Net Margin
CMBT
CMBT
SCL
SCL
Q1 26
3.3%
Q4 25
0.9%
Q3 25
1.8%
Q2 25
1.9%
Q1 25
3.3%
Q4 24
32.3%
0.6%
Q3 24
4.3%
Q2 24
1.7%
EPS (diluted)
CMBT
CMBT
SCL
SCL
Q1 26
$0.86
Q4 25
$0.22
Q3 25
$0.47
Q2 25
$0.50
Q1 25
$0.86
Q4 24
$1.01
$0.14
Q3 24
$1.03
Q2 24
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBT
CMBT
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$38.9M
Total DebtLower is stronger
$2.6B
$328.4M
Stockholders' EquityBook value
$1.2B
$1.2B
Total Assets
$3.9B
$2.3B
Debt / EquityLower = less leverage
2.20×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBT
CMBT
SCL
SCL
Q1 26
Q4 25
$132.7M
Q3 25
$118.5M
Q2 25
$88.9M
Q1 25
$107.5M
Q4 24
$38.9M
$99.7M
Q3 24
$147.3M
Q2 24
$124.7M
Total Debt
CMBT
CMBT
SCL
SCL
Q1 26
$328.4M
Q4 25
$626.7M
Q3 25
$655.5M
Q2 25
$658.0M
Q1 25
$659.3M
Q4 24
$2.6B
$625.4M
Q3 24
$688.5M
Q2 24
$657.1M
Stockholders' Equity
CMBT
CMBT
SCL
SCL
Q1 26
$1.2B
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
Total Assets
CMBT
CMBT
SCL
SCL
Q1 26
$2.3B
Q4 25
$2.4B
Q3 25
$2.4B
Q2 25
$2.4B
Q1 25
$2.4B
Q4 24
$3.9B
$2.3B
Q3 24
$2.4B
Q2 24
$2.3B
Debt / Equity
CMBT
CMBT
SCL
SCL
Q1 26
0.28×
Q4 25
0.50×
Q3 25
0.53×
Q2 25
0.53×
Q1 25
0.55×
Q4 24
2.20×
0.53×
Q3 24
0.56×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBT
CMBT
SCL
SCL
Operating Cash FlowLast quarter
$204.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.07×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBT
CMBT
SCL
SCL
Q1 26
Q4 25
$60.0M
Q3 25
$69.8M
Q2 25
$11.2M
Q1 25
$6.9M
Q4 24
$204.4M
$68.3M
Q3 24
$22.7M
Q2 24
$29.5M
Free Cash Flow
CMBT
CMBT
SCL
SCL
Q1 26
Q4 25
$25.4M
Q3 25
$40.2M
Q2 25
$-14.4M
Q1 25
$-25.8M
Q4 24
$32.1M
Q3 24
$-4.0M
Q2 24
$-208.0K
FCF Margin
CMBT
CMBT
SCL
SCL
Q1 26
Q4 25
4.6%
Q3 25
6.8%
Q2 25
-2.4%
Q1 25
-4.3%
Q4 24
6.1%
Q3 24
-0.7%
Q2 24
-0.0%
Capex Intensity
CMBT
CMBT
SCL
SCL
Q1 26
Q4 25
6.3%
Q3 25
5.0%
Q2 25
4.3%
Q1 25
5.5%
Q4 24
6.9%
Q3 24
4.9%
Q2 24
5.3%
Cash Conversion
CMBT
CMBT
SCL
SCL
Q1 26
Q4 25
11.99×
Q3 25
6.44×
Q2 25
0.99×
Q1 25
0.35×
Q4 24
1.07×
20.38×
Q3 24
0.96×
Q2 24
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBT
CMBT

Segment breakdown not available.

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons